Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • ISAMRA and TreadBinary Join Forces to Revolutionize Royalty Distribution Business
  • P&G Global Production – The Gateway For Indian Models In International Pageants Lifestyle
  • Franklin Industries Ltd foray in to Contract Farming Business Business
  • Singer Meenakshi Panges new song MAHI VE launch Entertainment
  • ATLAS SkillTech University and Whistling Woods International Launch Media & Entertainment Summer School for Classes 8 to 12 Education
  • Life Coach Forum & Falgun Talk About the Divine Hour Workshop Business
  • Those Who Care Are Making This World A Better Place Press Release
  • Can a Machine Lead? SBS University’s 17th National Debate Competition Puts Artificial Intelligence, Talent, and Human Judgment in the Dock Education

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • ACTIZEET Issues Guidelines to Help Consumers Identify Original Shilajit Health
  • The Hidden Dangers of Modern Lifestyle Habits: A Growing Cancer Concern Health
  • mediEND: Redefining Surgical Healthcare with Care, Commitment, and Compassion Health
  • IPSC Pain & Spine Hospital Organizes a Health camp in Collaboration with GMR Health
  • NEURIA – an App to Improve the Quality of Mental Health and Treatment of Neurological Patients and their Caregivers launched in India Health
  • Surat’s Sakhiya Skin Clinic Hosts First-Ever Live Training on Advanced APTOS Anti-Ageing Method by American Doctors Health

Recent Posts

  • India’s New Sovereign Arrival in Global Ultra-Luxury Timekeeping
  • The Return Of Shadows: When Entertainment Decided Happiness Was Overrated
  • Hettich Brings Its Magical Experience to Solapur with a New Hettich Exclusive (HeX) Store Launch
  • The Power of Cranberries: A Natural Boost for Gut Microbiome Health
  • Fabtech Technologies Cleanrooms Limited Crosses Rs 200 Crore in Revenue, PAT Grows 18.95% in FY2026

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Samridhhi Mandawat – the Youngest Female Author to have donated all the Royalties for Women Upliftment English
  • Yathakatha International Film & Literature Festival Season 2 Concluded On A Great Note Entertainment
  • Aspirational luxury brand Sastajoota witnessed 400% YoY growth since its inception in 2019 Lifestyle
  • Sotac Pharmaceuticals Ltd brings its IPO on 28th March, To be listed on NSE Emerge Platform Business
  • Third season of India Fashion Awards concluded in Delhi! Lifestyle
  • An IT company by IITians in Karnal takes their team to Thailand Business
  • Why is Certified Blackhat organising Cybercrimes to cut down trillion dollars in losses costing every year? Technology
  • Karmsavi’s Latest Punjabi Song “Kala Kurta” Takes YouTube by Storm with Over 2 Million Views Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme